Utilizing their knowledge and years of experience recruiting in the life sciences industry, The Chase Group has successfully secured a new Global Senior Medical Advisor, Medical Affairs, Thoracic Cancer for Eli Lilly. Following internal promotions within Eli Lilly’s leadership team, The Chase Group, Inc. was pleased to accept the assignment to backfill this key position. The successful candidate is a respected physician with an energetic passion for medical affairs and expertise in thoracic oncology. The Chase Group is proud to partner with Eli Lilly and have the opportunity to find the high caliber talent needed to execute the role of Medical Affairs as a strategic partner to accelerate access to medicine for the benefits of patients.
Eli Lilly Cyramza® Team Grows Through Continued Partnership with Chase
Utilizing their knowledge and years of experience recruiting in the life sciences industry, The Chase Group has successfully secured a new Global Senior Medical Advisor, Medical Affairs, Thoracic Cancer for Eli Lilly. Following internal promotions within Eli Lilly’s leadership team, The Chase Group, Inc. was pleased to accept the assignment to backfill this key position. The successful candidate is a respected physician with an energetic passion for medical affairs and expertise in thoracic oncology. The Chase Group is proud to partner with Eli Lilly and have the opportunity to find the high caliber talent needed to execute the role of Medical Affairs as a strategic partner to accelerate access to medicine for the benefits of patients.
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,…